Bendectin and Birth Defects II: Ecological Analyses

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 2, 2003, Pages 88-97

  Kutcher, Jeffrey S ^a   Engle, Arnold ^b   Firth, Jacqueline ^c   Lamm, Steven H ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Epidemiology and Occupational Health Inc   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDECTIN; ANTIEMETIC AGENT; DOXYLAMINE; PYRIDOXINE;

ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; COHORT ANALYSIS; CONGENITAL MALFORMATION; DRUG MARKETING; ECOLOGY; EPIDEMIOLOGICAL DATA; HOSPITALIZATION; HUMAN; HYPOTHESIS; META ANALYSIS; NAUSEA; PREGNANCY; PRIORITY JOURNAL; TERATOGENESIS; UNITED STATES; VOMITING; ADULT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG APPROVAL; DRUG COMBINATION; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FEMALE; FETUS; FOOD AND DRUG ADMINISTRATION; INCIDENCE; LEGAL LIABILITY; MULTIPLE MALFORMATION SYNDROME; NEWBORN; PREGNANCY COMPLICATION; SAFETY; STATISTICS;

ABNORMALITIES, DRUG-INDUCED; ABNORMALITIES, MULTIPLE; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANIMALS; ANTIEMETICS; DOXYLAMINE; DRUG APPROVAL; DRUG COMBINATIONS; DRUG UTILIZATION; FEMALE; FETUS; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT, NEWBORN; LIABILITY, LEGAL; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIDOXINE; SAFETY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VOMITING;

EID: 0141924096     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10034     Document Type: Article

References (16)

1. Aselton P, Jick H, Chentow SJ, Perera DR, Hunter JH. 1984. Pyloric stenosis and maternal Bendectin exposure. Am J Epidemiol 120:251.
2. Brent RL. 2001. The history of the editorship of teratology during the period from July 1, 1976 to January 1, 1993. Teratology 63:100-105.
3. Einarson TR, Leeder JS, Koren G. 1988. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm 22:813-824.
4. Engel A, Lamm SH. 1989. Temporal changes in drug use during pregnancy 1980-85, USA. J Clin Res Drug Dev 3:209.
5. Eskenazi B, Bracken MB. 1982. Bendectin (Debendox) as a risk factor for pyloric stenosis. Am J Obstet Gynecol 144:919-924.
6. FDA Drug Bulletin, Volume 11, Number 1 (March 1981) at p. 1.
7. Fleming DM, Knox JDE, Crombie DL. 1981. Debendox in early pregnancy and fetal malformation. BMJ 283:99-101.
8. Gadsby R, Barnie-Adshead AM, Jagger CA. 1993. Prospective study of nausea and vomiting in pregnancy. Br J Gen Pract 43:245-248.
9. Golding J, Vivian S, Baldwin JA. 1983. Maternal anti-nauseants and cleft of lip and palate. Human Toxicol 2:63-73.
10. Jick SS, Garrison JM. 1988. Discontinuation of Bendectin (letter). Am J Pub Health 78:322.
11. Lamm SH. 1984. Bendectin: final report. Submitted through Samuel H. Porter, guardium ad litem, to Judge Carl Rubin, US District Court for the Southern District of Ohio. In re: Richardson-Merrell, Inc.: " Bendectin" Product Liability Litigation, MDL No. 486.
12. McKeigue PM, Lamm SH, Linn S, Kutcher JS. 1994. Bendectin and birth defects: I. a meta-analysis of the epidemiologic studies. Teratology 50:27-37.
13. Mitchell A, Rosenberg L, Shapiro S, Slone D. 1981. Birth defects related to Bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA 245:2311-2314.
14. Neutel CI. 2000. Variation in rates of hospitalization for excessive vomiting in pregnancy by Bendectin/Diclectin use in Canada. Nausea and vomiting of pregnancy: state of the art 2000. Toronto: Motherisk, the Hospital for Sick Children 1:54-59.
15. Rothman KJ, Fyler DC, Goldblatt A, Kreidberg MB. 1979. Exogenous hormones and other drug exposures of children with congenital heart disease. Am J Epidemiol 109:433-439.
16. Tierson FD. 1986. Nausea and vomiting of pregnancy and association with pregnancy outcome. Am J Obstet Gynecol 155:1017-1022.